Why do you think that people at basherville are co
Post# of 72440
because they want to know how long they have to keep shorting the stock.
I'm real happy to be totally in the dark about when we can expect the analysis.
now think about this:
You have 199 people. The have "before" photos, and "after" photos. They have to be interviewed to see how they subjectively feel that their psoriasis is (remember, in the first clinical trial, some people said that their skin was less itchy and felt less dry).
Now, you have to have a doctor look at the photos and decide what score to assign them before, and after. Or perhaps the same doctor who examined them initially makes another assesment. This is a subjective judgment and they don't have some hard number from something like a blood test or other way of getting an objective number.
So, do this 199 times, with different doctors making the judgments at each site. We don't know the details, but it's possible that someone may be looking at photos for each of those 199 patients to make a second determination of efficacy.
Now, they have to look at the amount of improvement, and look at how big a dose they got. You have two DIFFERENT doses plus the placebo group.
Seems pretty obvious to me that doing this, looking at each group, gauging amount of improvement (or no improvement) for each, factoring in dosage, and consolidating all this -- is going to take significant time.
I much prefer that they are sure that their data is absolutely correct and cannot be questioned, rather than them rushing to put out incomplete data.
But then, I'm long this stock, and don't listen to the bashers who are trying to get the information on the timing of the data release so that they can short with impunity.